QUIDELORTHO CORP (QDEL)       69.86  -2.34 (-3.24%)

69.86  -2.34 (-3.24%)

US2197981051 - Common Stock - After market: 69.86 0 (0%)

QUIDELORTHO CORP69.86

NASDAQ:QDEL (9/27/2022, 7:10:49 PM)-2.34 (-3.24%)

After market: 69.86 0 (0%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Health Care Equipment & Supplies
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 08-04 2022-08-04/amc Earnings (Next) 11-02 2022-11-02
Ins Owners 1.51% Inst Owners 2.71%
Market Cap 2.92B Shares 41.85M
PE 2.62 Fwd PE 12.79
Dividend Yield N/A Analysts 78.33
IPO 08-05 1981-08-05

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

QDEL Daily chart

Company Profile

Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. The company is headquartered in San Diego, California and currently employs 1,600 full-time employees. The Company’s diagnostic testing solutions are separated into four product categories: rapid immunoassay, cardiometabolic immunoassay, molecular diagnostic solutions and specialized diagnostic solutions. Its diagnostic testing solutions under various brand names, including Quidel, QuickVue, QuickVue+, QVue, Sofia, Triage, Solana, Virena, MicroVue, Lyra, FreshCells, D3, FastPoint, ReadyCells, InflammaDry, AdenoPlus, ELVIRA, ELVIS, Thyretain and Savanna. The firm sells its products directly to end-users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers, as well as for individual, non-professional, over-the-counter (OTC) use.

Company Info

QUIDELORTHO CORP

9975 Summers Ridge Road

San Diego CALIFORNIA 92121

P: 18585521100.0

CEO: Douglas C. Bryant

Employees: 1600

Website: http://www.quidel.com/

QDEL Twits

Here you can normally see the latest stock twits on QDEL, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example